Previously, we found that mutant Kras transcriptionally activates Gfpt1 expression downstream of MAPK signaling in a murine model of PDA to facilitate HBP activity (Ying et al., 2012). The gene discussed is GFPT1; the disease is Patent ductus arteriosus.